dc.contributor.author |
Abebe,A |
|
dc.contributor.author |
Nokes,David |
|
dc.contributor.author |
Dejene,Amare |
|
dc.contributor.author |
Enqueselassie,Fikre |
|
dc.contributor.author |
Messele,Tsehaynesh |
|
dc.contributor.author |
Cutts, Felicty |
|
dc.date.accessioned |
2022-11-24T10:13:28Z |
|
dc.date.available |
2022-11-24T10:13:28Z |
|
dc.date.issued |
03/13/2003 |
|
dc.identifier.citation |
Abebe, A & Nokes, david & Dejene, A & Enqueselassie, Fikre & Messele, Tsehaynesh & Cutts, F. (2003). Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: Transmission patterns and vaccine control. Epidemiology and infection. 131. 757-70. |
|
dc.identifier.uri |
http://172.21.6.100:8080/xmlui/handle/123456789/179 |
|
dc.description.abstract |
A community-based seroepidemiological survey of Addis Ababa, Ethiopia was conducted in 1994 to inform on the transmission dynamics and control of hepatitis B virus (HBV) infection. Venous blood from 4736 individuals under 50 years of age from 1262 households, selected using stratified cluster-sampling, was screened for HBV markers using commercial ELISAs. HBsAg prevalence was 7% (95% CI 6–8), higher in males (9%; 7–10) than females (5%; 4–6). HBeAg prevalence
in HBsAg positives was 23% (18–29), and less than 1% of women of childbearing age were HBeAg positive. Overall HBV seroprevalence (any marker), rose steadily with age to over 70% in 40– 49 year olds, indicating significant childhood and adult transmission. Estimated instantaneous incidence was 3– 4/100 susceptibles/year, higher in males than females in 0–4 year olds, and peaking in early childhood and young adults. The age at which 50% had evidence of infection was around 20 years, and the herd immunity threshold is approximated at 63–77%. Addis Ababa
is of intermediate-high HBV endemicity, with negligible perinatal transmission. Our main findings are the identification of a significant difference between males and females in the age-acquisition of HBV infection, and marked differences between age groups in HBV incidence rates. These results should target future research studies of underlying risk factors. Furthermore, we generate a crude estimate of the level of coverage of HBV vaccine that would be required to eliminatethe virus from the study population. |
|
dc.format.extent |
757-770 |
|
dc.title |
Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control |
|
dc.type |
Journal Article |
|
ep.identifier.status |
Open Access |
|
ep.identifier.status |
Open Access |
|
ep.identifier.doi |
https://doi.org/10.1017/s0950268803008574 |
|
ep.journal |
Epidemiology and infection |
|
ep.issue |
1 |
|
ep.volume |
131 |
|